Dianthus Therapeutics Inc (DNTH) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Dianthus Therapeutics Inc   (NASDAQ: DNTH)

Dianthus Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




DNTH Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 74.24 % 71.46 % 55.11 %
Gross Margin (Q2 TTM) 47.19 % 74.52 % 68.39 % 49.4 %
Gross Profit Margin 5 Yr. Avg. - 67.82 % 65.56 % 47.82 %
EBITDA Margin (Q2 MRQ) 4.86 % 25.29 % 22.25 % 23.73 %
EBITDA Margin (Q2 TTM) -7014.16 % 21.23 % 19.16 % 20.39 %
EBITDA Margin 5 Yr. Avg. - 47.09 % 31.58 % 22.44 %
Operating Margin (Q2 MRQ) -8079.11 % 22.46 % 19.05 % 20.92 %
Operating Margin (Q2 TTM) -15117.56 % 17.54 % 15.8 % 17.7 %
Operating Margin 5 Yr. Avg. - 15.37 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 19.07 % 14.98 % 12.27 %
Pre-Tax Profit Margin (Q2 TTM) -7022.69 % 15.78 % 13.04 % 12.46 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.99 % 10.37 % 12.42 %
Net Margin (Q2 MRQ) -6598.55 % 16.86 % 12.95 % 10.15 %
Net Margin (Q2 TTM) -13341.15 % 20.6 % 14.99 % 10.36 %
Net Margin 5 Yr. Avg. - 5.8 % 6.08 % 9.9 %



Business Segment Profit Margin
 
License
  Explore License Segment  -